Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value: $1.057B (100.0% shares, 0.0% debt)

Holdings (29)

BMRN BIOMARIN PHARMACEUTICAL INC 15.3%
Value $162M Shares 1,831,035 Share Price $88.48 Est. Cost/Share $83.16 Unrealized @ Report Date +7.0%
INSM INSMED INC 14.1%
Value $149M Shares 5,889,491 Share Price $25.25 * Est. Cost/Share $17.79 Unrealized @ Report Date +28.5%
UTHR UNITED THERAPEUTICS CORP 12.3%
Value $130M Shares 575,907 Share Price $225.87 Est. Cost/Share $89.23 Unrealized @ Report Date +158.1%
FOLD AMICUS THERAPEUTICS INC 12.1%
Value $128M Shares 10,524,022 Share Price $12.16 * Est. Cost/Share $9.63 Unrealized @ Report Date +34.0%
BIIB BIOGEN INC 9.3%
Value $97.99M Shares 381,282 Share Price $257.01 * Est. Cost/Share $264.98 Unrealized @ Report Date +0.9%
PRTA PROTHENA CORP PLC 7.6%
Value $79.97M Shares 1,657,458 Share Price $48.25 * Est. Cost/Share $21.46 Unrealized @ Report Date +176.9%
— REVANCE THERAPEUTICS INC 5.7%
Value $59.97M Shares 5,228,609 Share Price $11.47 Est. Cost/Share $21.40 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 5.2%
Value $55.24M Shares 1,374,822 Share Price $40.18 * Est. Cost/Share $24.23 Unrealized @ Report Date +93.3%
ACAD ACADIA PHARMACEUTICALS INC 4.7%
Value $50.14M Shares 2,405,793 Share Price $20.84 * Est. Cost/Share $28.41 Unrealized @ Report Date -4.4%
— SAGE THERAPEUTICS INC 2.0%
Value $20.7M Shares 1,005,776 Share Price $20.58 Est. Cost/Share $42.84 Unrealized @ Report Date —
EHTH EHEALTH INC 1.9%
Value $20.27M Shares 2,739,379 Share Price $7.40 * Est. Cost/Share $38.13 Unrealized @ Report Date -79.4%
ALGN ALIGN TECHNOLOGY INC 1.6%
Value $17.01M Shares 55,705 Share Price $305.32 * Est. Cost/Share $149.18 Unrealized @ Report Date +131.6%
ALKS ALKERMES PLC 1.6%
Value $16.9M Shares 603,400 Share Price $28.01 * Est. Cost/Share $22.36 Unrealized @ Report Date +31.1%
SRPT SAREPTA THERAPEUTICS INC 1.1%
Value $11.4M Shares 94,030 Share Price $121.22 * Est. Cost/Share $128.81 Unrealized @ Report Date -12.3%
NVCR NOVOCURE LTD 1.0%
Value $10.66M Shares 660,275 Share Price $16.15 * Est. Cost/Share $58.84 Unrealized @ Report Date -51.0%
ANAB ANAPTYSBIO INC 0.7%
Value $7.745M Shares 431,224 Share Price $17.96 * Est. Cost/Share $19.06 Unrealized @ Report Date +0.1%
— KARYOPHARM THERAPEUTICS INC 0.7%
Value $7.606M Shares 5,675,876 Share Price $1.34 Est. Cost/Share $16.36 Unrealized @ Report Date —
— NEVRO CORP 0.7%
Value $7.435M Shares 386,832 Share Price $19.22 Est. Cost/Share $22.21 Unrealized @ Report Date —
SNDX SYNDAX PHARMACEUTICALS INC 0.6%
Value $6.862M Shares 472,600 Share Price $14.52 * Est. Cost/Share $16.84 Unrealized @ Report Date +12.3%
GOSS GOSSAMER BIO INC 0.5%
Value $5.438M Shares 6,530,288 Share Price $0.83 * Est. Cost/Share $1.61 Unrealized @ Report Date -28.6%
CYTK CYTOKINETICS INC 0.3%
Value $3.291M Shares 111,717 Share Price $29.46 * Est. Cost/Share $6.71 Unrealized @ Report Date +396.1%
RLMD RELMADA THERAPEUTICS INC 0.2%
Value $2.197M Shares 732,400 Share Price $3.00 Est. Cost/Share $3.27 Unrealized @ Report Date -9.2%
MIRM MIRUM PHARMACEUTICALS INC 0.2%
Value $2.045M Shares 64,700 Share Price $31.60 * Est. Cost/Share $15.56 Unrealized @ Report Date +76.0%
TVTX TRAVERE THERAPEUTICS INC 0.1%
Value $1.485M Shares 166,069 Share Price $8.94 * Est. Cost/Share $23.56 Unrealized @ Report Date -40.1%
VNDA VANDA PHARMACEUTICALS INC 0.1%
Value $1.205M Shares 278,985 Share Price $4.32 * Est. Cost/Share $11.21 Unrealized @ Report Date -50.5%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $1.074M Shares 160,800 Share Price $6.68 * Est. Cost/Share $7.10 Unrealized @ Report Date +4.6%
— KEZAR LIFE SCIENCES INC 0.1%
Value $781K Shares 656,200 Share Price $1.19 Est. Cost/Share $5.16 Unrealized @ Report Date —
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value $381K Shares 27,100 Share Price $14.05 * Est. Cost/Share $39.74 Unrealized @ Report Date -50.7%
URGN UROGEN PHARMA LTD 0.0%
Value $343K Shares 24,500 Share Price $14.01 * Est. Cost/Share $27.01 Unrealized @ Report Date -40.6%